-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $19 Price Target

Benzinga·05/08/2025 09:53:19
Listen to the news
Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and maintains $19 price target.